TP53 and cancer: Although ATF3 was reported to decrease the p53 mRNA level in human umbilical vein endothelial cells and human keratinocytes [47, 48], it is worth noting that this contrary effect likely limits to specific cell types as we have never seen such an effect in either primary or cancer cells that we intensively investigated.